Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma

Lei Huang, Sarah Garrett Injac, Kemi Cui, Frank Braun, Lin Qi, Yuchen Du, Huiyuan Zhang, Mari Kogiso, Holly Lindsay, Sibo Zhao, Patricia Baxter, Adesina Adekunle, Tsz Kwong Man, Hong Zhao, Xiaonan Li, Ching C. Lau, Stephen T.C. Wong*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology